EPISTAXOL

This brand name is authorized in Spain

Active ingredients

The drug EPISTAXOL contains a combination of these active pharmaceutical ingredients (APIs):

1 Phenazone
UNII T3CHA1B51H - ANTIPYRINE

Phenazone has analgesic and antipyretic properties. Topically, solutions have been used locally as ear drops in disorders such as otitis media because of its local anti-inflammatory and analgesic action.

Read about Phenazone
2 Rutoside
UNII 5G06TVY3R7 - RUTIN
Read about Rutoside
3 Naphazoline
UNII H231GF11BV - NAPHAZOLINE

Naphazoline is a sympathomimetic amine with pronounced alpha adrenergic activity and as a consequence has vasoconstrictor activity.

Read about Naphazoline
4 Epinephrine
UNII YKH834O4BH - EPINEPHRINE

Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation.

Read about Epinephrine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B02BC30 Combinations B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BC Local hemostatics
Discover more medicines within B02BC30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 42972

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.